Together our findings suggest that GPER-1 plays a key role in the mechanisms of tamoxifen resistance of estrogen-sensitive breast cancer cells, extending the limits of understanding of the effects generated by tamoxifen in these cells. The gene discussed is GPER1; the disease is breast cancer.